|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Fixed maturity, bonds held-to-maturity, at amortized cost, net of allowance for credit losses of $13,388 in 2022 and $13,129 in 2021 (Fair value $6,828,253 in 2022 and $7,458,789 in 2021) | ||||||||
| Fixed maturity, bonds available-for-sale, at fair value (Allowance for credit losses of $28,420 in 2022 and $10,310 in 2021) (Amortized cost $9,824,697 in 2022 and $8,107,794 in 2021) | ||||||||
| Equity securities, at fair value (Cost $95,317 in 2022 and $94,732 in 2021) | ||||||||
| Mortgage loans on real estate, net of allowance for credit losses of $92,824 in 2022 and $97,079 in 2021 | ||||||||
| Policy loans | ||||||||
| Investment real estate, net of accumulated depreciation of $269,626 in 2020 and $256,757 in 2019 | ||||||||
| Real estate and real estate partnerships, net of accumulated depreciation of $286,999 in 2022 and $287,387 in 2021 | ||||||||
| Investment funds | ||||||||
| Short-term investments | ||||||||
| Other invested assets | ||||||||
| Total investments | ||||||||
| Cash and cash equivalents | ||||||||
| Investments in unconsolidated affiliates | ||||||||
| Accrued investment income | ||||||||
| Reinsurance recoverables, net of allowance for credit losses of $14,725 in 2022 and $14,553 in 2021 | ||||||||
| Prepaid reinsurance premiums | ||||||||
| Premiums due and other receivables | ||||||||
| Deferred policy acquisition costs | ||||||||
| Property and equipment, net of accumulated depreciation of $307,897 in 2022 and $302,936 in 2021 | ||||||||
| Current tax receivable | ||||||||
| Prepaid pension | ||||||||
| Other assets | ||||||||
| Separate account assets | ||||||||
| Total assets | ||||||||
| LIABILITIES | ||||||||
| Future policy benefits | ||||||||
| Life | ||||||||
| Annuity | ||||||||
| Health | ||||||||
| Policyholders’ account balances | ||||||||
| Policy and contract claims | ||||||||
| Unearned premium reserve | ||||||||
| Other policyholder funds | ||||||||
| Liability for retirement benefits | ||||||||
| Notes payable | ||||||||
| Deferred tax liabilities, net | ||||||||
| Current tax payable | ||||||||
| Federal Home Loan Bank advance | ||||||||
| Other liabilities | ||||||||
| Separate account liabilities | ||||||||
| Total liabilities | ||||||||
| EQUITY | ||||||||
| American National Group, Inc. stockholders’ equity: | ||||||||
| Common stock, $0.01 par value; 50,000,000 shares authorized; 26,887,200 shares issued and outstanding in 2022 and 2021 | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated other comprehensive income (loss) | ||||||||
| Retained earnings | ||||||||
| Treasury stock, at cost | ||||||||
| Total American National stockholders’ equity | ||||||||
| Noncontrolling interest | ||||||||
| Total stockholders' equity | ||||||||
| Total liabilities and stockholders' equity |
Loading...
